Skip to main content
OpenTrials

Clinical trial condition

Neoplasms

Explore clinical trials studying Neoplasms. Study availability and eligibility vary by location and protocol.

7,968 public trials 1,514 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms trial results

Completed

A Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive Tumors

NCT01738451

Conditions
Cancer, Neoplasms
Locations
  • GSK Investigational Site Scottsdale, Arizona, United States
  • GSK Investigational Site Memphis, Tennessee, United States
  • GSK Investigational Site Nashville, Tennessee, United States
  • GSK Investigational Site San Antonio, Texas, United States
View Trial Details
Completed

A Phase I, Open-Label, First-Time-In-Human Study of the Oral AKT Inhibitor GSK2141795

NCT00920257

Conditions
Breast Diseases, Breast Neoplasms, Cancer, +21 more
Locations
  • GSK Investigational Site Baltimore, Maryland, United States
  • GSK Investigational Site Boston, Massachusetts, United States
  • GSK Investigational Site New York, United States
  • GSK Investigational Site Oklahoma City, Oklahoma, United States
View Trial Details
Completed

Safety, Pharmacokinetics (PK) of AKT and MEK Combination

NCT01138085

Conditions
Breast Diseases, Breast Neoplasms, Cancer, +15 more
Locations
  • GSK Investigational Site Aurora, Colorado, United States
  • GSK Investigational Site New Haven, Connecticut, United States
  • GSK Investigational Site Boston, Massachusetts, United States
  • GSK Investigational Site Boston, Massachusetts, United States
View Trial Details
Completed

Safety and Tolerability Study of GSK1120212, a MEK Inhibitor, in Combination With Docetaxel, Erlotinib, Pemetrexed, Pemetrexed + Carboplatin, Pemetrexed + Cisplatin, or Nab-Paclitaxel

NCT01192165

Conditions
Cancer, Neoplasms
Locations
  • GSK Investigational Site Scottsdale, Arizona, United States
  • GSK Investigational Site Duarte, California, United States
  • GSK Investigational Site Sacramento, California, United States
  • GSK Investigational Site Denver, Colorado, United States
View all 20 locations
View Trial Details
Completed

GSK1120212 Food-effect Study

NCT01371487

Conditions
Cancer, Neoplasms
Locations
  • GSK Investigational Site Detroit, Michigan, United States
  • GSK Investigational Site Nashville, Tennessee, United States
  • GSK Investigational Site San Antonio, Texas, United States
View Trial Details
Completed

A Phase I Topotecan Study in Subjects With Cancer and Impaired Renal Function

NCT00483860

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +6 more
Locations
  • GSK Investigational Site Scottsdale, Arizona, United States
  • GSK Investigational Site Lebanon, New Hampshire, United States
  • GSK Investigational Site Amsterdam, Netherlands
  • GSK Investigational Site Utrecht, Netherlands
View Trial Details

Related conditions